BACKGROUND: Alcohol-related peripheral neuropathy (ALN) is generally characterized as an axonal large-fiber polyneuropathy caused by thiamine deficiency. We hypothesized, based on clinical observations, that ALN is associated with a small-fiber polyneuropathy that can be diagnosed with skin biopsy in heavy alcohol drinking subjects with normal thiamine status. METHODS: Eighteen individuals (9 heavy alcohol drinking subjects and 9 healthy control subjects) were assessed for the potential utility of skin biopsies in detecting ALN-associated small nerve fiber degeneration. Heavy drinking was defined as greater than 4 drinks/d and 5 drinks/d in women and men, respectively, as determined by the Timeline Follow-Back and lifetime drinking history. All subjects underwent neurological examination, nerve conduction studies, and skin biopsies to quantify end nerve fiber densities (ENFD). Other causes of neuropathy were excluded and thiamine status was assessed. RESULTS: Average ENFD were significantly decreased at the calf in the alcohol group as compared with control group (p < 0.0001). Histological sections demonstrated striking attrition and architectural simplification of intraepidermal nerve fibers in the heavy alcohol drinking subjects. There were no significant intergroup differences with respect to clinical assessments of neuropathy or thiamine status. CONCLUSIONS: ALN is associated with a small-fiber neuropathy that can be detected with skin biopsy in heavy alcohol drinking individuals with normal thiamine status. Skin biopsy is a useful, minimally invasive biomarker that could extend studies to understand the effect of alcohol on the peripheral nerves and to evaluate potential therapeutic agents in larger clinical trials.
BACKGROUND:Alcohol-related peripheral neuropathy (ALN) is generally characterized as an axonal large-fiber polyneuropathy caused by thiamine deficiency. We hypothesized, based on clinical observations, that ALN is associated with a small-fiber polyneuropathy that can be diagnosed with skin biopsy in heavy alcohol drinking subjects with normal thiamine status. METHODS: Eighteen individuals (9 heavy alcohol drinking subjects and 9 healthy control subjects) were assessed for the potential utility of skin biopsies in detecting ALN-associated small nerve fiber degeneration. Heavy drinking was defined as greater than 4 drinks/d and 5 drinks/d in women and men, respectively, as determined by the Timeline Follow-Back and lifetime drinking history. All subjects underwent neurological examination, nerve conduction studies, and skin biopsies to quantify end nerve fiber densities (ENFD). Other causes of neuropathy were excluded and thiamine status was assessed. RESULTS: Average ENFD were significantly decreased at the calf in the alcohol group as compared with control group (p < 0.0001). Histological sections demonstrated striking attrition and architectural simplification of intraepidermal nerve fibers in the heavy alcohol drinking subjects. There were no significant intergroup differences with respect to clinical assessments of neuropathy or thiamine status. CONCLUSIONS:ALN is associated with a small-fiber neuropathy that can be detected with skin biopsy in heavy alcohol drinking individuals with normal thiamine status. Skin biopsy is a useful, minimally invasive biomarker that could extend studies to understand the effect of alcohol on the peripheral nerves and to evaluate potential therapeutic agents in larger clinical trials.
Authors: B G McCarthy; S T Hsieh; A Stocks; P Hauer; C Macko; D R Cornblath; J W Griffin; J C McArthur Journal: Neurology Date: 1995-10 Impact factor: 9.910
Authors: Suzanne M de la Monte; Jong-Eun Yeon; Ming Tong; Lisa Longato; Rajeev Chaudhry; Mao-Yin Pang; Kevin Duan; Jack R Wands Journal: J Gastroenterol Hepatol Date: 2008-05-26 Impact factor: 4.029
Authors: Francesco De Logu; Simone Li Puma; Lorenzo Landini; Francesca Portelli; Alessandro Innocenti; Daniel Souza Monteiro de Araujo; Malvin N Janal; Riccardo Patacchini; Nigel W Bunnett; Pierangelo Geppetti; Romina Nassini Journal: J Clin Invest Date: 2019-12-02 Impact factor: 14.808
Authors: Johanna Seitz; Kayle S Sawyer; George Papadimitriou; Marlene Oscar-Berman; Isaac Ng; Antoni Kubicki; Palig Mouradian; Susan M Ruiz; Marek Kubicki; Gordon J Harris; Nikos Makris Journal: Brain Imaging Behav Date: 2017-08 Impact factor: 3.978
Authors: Jessica R Lakritz; Ayman Bodair; Neal Shah; Ryan O'Donnell; Michael J Polydefkis; Andrew D Miller; Tricia H Burdo Journal: Am J Pathol Date: 2015-05-05 Impact factor: 4.307
Authors: Paweł Wiśniewski; Pierre Maurage; Andrzej Jakubczyk; Elisa M Trucco; Hubert Suszek; Maciej Kopera Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2021-07-03 Impact factor: 5.067
Authors: B T A de Greef; J G J Hoeijmakers; C M L Gorissen-Brouwers; M Geerts; C G Faber; I S J Merkies Journal: Eur J Neurol Date: 2017-12-18 Impact factor: 6.089
Authors: Jacek Baj; Alicja Forma; Joanna Kobak; Magdalena Tyczyńska; Iga Dudek; Amr Maani; Grzegorz Teresiński; Grzegorz Buszewicz; Jacek Januszewski; Jolanta Flieger Journal: Int J Environ Res Public Health Date: 2022-03-06 Impact factor: 3.390